Prosecution Insights
Last updated: October 02, 2026

Examiner: RABAGLIA, BRIDGET ELIZABETH

Tech Center 3700 • Art Units: 3771 3774

This examiner grants 68% of resolved cases

Analysis

RABAGLIA, BRIDGET ELIZABETH is an examiner in Tech Center 3700 and Art Unit 3771. The examiner has 178 resolved cases. The allowance rate for these cases is 68.5 percent. Practitioners should use this information when advising clients on the likelihood of a patent grant. The volume of dispositions provides a basis for statistical analysis of the examiner's record. This percentage informs the expectations for an outcome during the prosecution process.

The median days to allowance is 1089. This timeline represents the duration from filing to a grant. The pendency figure is a factor for managing portfolio expectations and planning filings. Applicants should prepare for the prosecution process by considering this time requirement. The duration of the examination is a component of the experience in Tech Center 3700.

The interview lift is 15.9 percent. This figure indicates the correlation between an interview and an allowance. Engaging in dialogue with the examiner is a factor to consider for applicants in Art Unit 3771. The impact of interviews is a metric for this docket. This 15.9 percent lift is a data point for strategy development. These statistics offer a view of the examiner's performance and tendencies. This analysis provides a baseline for expectations during the patent examination process.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

68.5%
Allow Rate
-1.5% vs TC avg
217
Total Applications
+15.9%
Interview Lift
1089
Avg Prosecution Days
Based on 178 resolved cases, 2023–2026

Rejection Statute Breakdown

0.7%
§101 Eligibility
29.3%
§102 Novelty
46.7%
§103 Obviousness
18.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19228394 WIDE HEMOSTASIS CLIP Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
19215929 LEFT ATRIAL APPENDAGE CLOSURE DEVICE Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18899785 HYBRID TRANSSEPTAL DILATOR AND METHODS OF USING THE SAME Non-Final OA Boston Scientific Medical Device Limited
19070951 SOFT ANCHORING TISSUE REPAIR ASSEMBLY AND SYSTEM Non-Final OA Smith & Nephew Asia Pacific Pte. Limited
19264227 VARIABLE-STIFFNESS DISTAL EXTENSION FOR A BLOOD PUMP SYSTEM Non-Final OA ABIOMED, Inc.
18812037 TREATMENT INSTRUMENT WITH VIBRATION GENERATING DEVICE Final Rejection OLYMPUS CORPORATION
17888734 FLOATING HEMOSTASIS VALVE Final Rejection Biosense Webster (Israel) Ltd.
19059434 Surgical Instrument and Methods of Tissue Repair Non-Final OA Arthrex, Inc.
18609038 ELONGATED MEDICAL BODY Non-Final OA TERUMO KABUSHIKI KAISHA
19123848 CHEST TUBE INSERTER FOR CHEST TUBE INSERTION AND DRUG INJECTION, AND KIT INCLUDING SAME Non-Final OA SEOUL NATIONAL UNIVERSITY HOSPITAL
18860828 DEVICES FOR TREATMENT OF VASCULAR DEFECTS Final Rejection MICROVENTION, INC.
17457316 SURGICAL INSTRUMENT WITH FLEXIBLE END EFFECTOR Non-Final OA GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
19123732 THROMBUS REMOVAL SYSTEMS AND METHODS FOR BLOOD RETURN AND RECONSTITUTING REMOVED BLOOD CLOTS Non-Final OA Shifamed Holdings, LLC
17112767 SYNDESMOSIS INSERTION CONSTRUCT Final Rejection In2Bones USA, LLC
18855971 SUTURE FOR USE IN FLEXIBLE ENDOSCOPIC SURGERIES Non-Final OA National University Corporation Chiba University
18714024 TOOLS FOR MICROSURGICAL PROCEDURES Non-Final OA ForSight Robotics Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month